Aurora Cannabis (ACB) Total Debt Growth (1y) (2019 - 2026)
Aurora Cannabis (ACB) Total Debt Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.50 Bn | 29.82 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.87 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 41.53% |
| 10 | Aurora Cannabis | 233.76 Mn | 161.45 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.25% |
| Dec 31, 2025 | -86.76% |
| Sep 30, 2025 | -85.88% |
| Jun 30, 2025 | -65.21% |
| Mar 31, 2025 | 14.16% |
| Dec 31, 2024 | -3.26% |
| Sep 30, 2024 | -26.46% |
| Jun 30, 2024 | -37.78% |
| Mar 31, 2024 | -0.30% |
| Dec 31, 2023 | 119.69% |
| Sep 30, 2023 | 170.39% |
| Jun 30, 2023 | 1,342.93% |
| Mar 31, 2023 | 15,457.64% |
| Dec 31, 2022 | 18,407.33% |
| Sep 30, 2022 | 12,945.46% |
| Jun 30, 2022 | 2,824.44% |
| Mar 31, 2022 | 18.34% |
| Dec 31, 2021 | 22.13% |
| Sep 30, 2021 | 59.61% |
| Jun 30, 2021 | -97.18% |